Ronnie Andrews has more than 25 years of experience in the diagnostics industry. He served as the President of Medical Sciences at Life Technologies Corporation from February 2, 2012 to June 26, 2013.
Mr. Andrews served as the Chief Executive Officer of Clarient Inc. (formerly Chromavision Medical Systems Inc.) since July 22, 2004. He served as Chief Executive Officer of GE Molecular Diagnostics. Mr. Andrews served as the President of Clarient Inc. from July 22, 2004 to April 2008. From August 2002, he served as Senior Vice President Global Marketing and Commercial Business Development at Pleasanton, CA-based Roche Molecular Diagnostics, where he developed and led the strategic execution for all diagnostic commercial operations. Mr. Andrews was also responsible for executive direction of all marketing functions, directed the development of the 10-year Strategic Plan for the organization, and completed the reorganization of commercial operations during that period.
From 2000 to 2002, Mr. Andrews held two senior executive positions with Indianapolis-based Roche Diagnostics Corporation. He served as Vice President of U.S. Commercial Operations at Molecular Diagnostics and directed sales, marketing, technical field support, and product development activities and was responsible for U.S. commercial strategy development for the clinical laboratory market. He served as Vice President of Marketing at U.S. Commercial Operations and was responsible for planning and directing all aspects of the Roche U.S. Laboratory Systems Commercial Operations Marketing which included the clinical chemistry, immunochemistry, hematology, near patient testing and molecular markets.
From 1995 to 2000 Mr. Andrews served as Vice President of marketing of Atlanta-based Immucor Inc. where he helped lead the transition of that company from a reagent manufacturer to an instrument systems company. Prior to Immucor, he spent almost 10 years in management positions of increasing responsibility at Chicago-based Abbott Diagnostics, culminating in…